Obagi Medical Products, Inc.
DelistedCIK 1375247fmd_0VPGRPK7M0XDK9W39E591B719WManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Mar 14, 2013, 13 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 |
|---|---|---|---|---|
| Total revenues | 104 | 113 | 114 | 121 |
| Cost of revenue | 22 | 24 | 24 | 25 |
| Gross profit | 82 | 89 | 90 | 96 |
| Research and development | 4 | 4 | 2 | 2 |
| Selling, general and administrative | 59 | 69 | 72 | 66 |
| Operating income | 18 | 16 | 16 | 27 |
| Interest expense | 0 | 0 | 0 | 0 |
| Interest and investment income | 0 | 0 | 0 | 0 |
| Income before taxes | 18 | 16 | 16 | 27 |
| Income tax expense | 7 | 6 | 6 | 11 |
| Net income from continuing operations | 11 | 9 | 10 | 17 |
| Net income | 11 | 9 | 10 | 17 |